Menu Search
Equities

CStone Pharmaceuticals

PH4:BER

CStone Pharmaceuticals

Actions
  • Price (EUR)0.238
  • Today's Change0.004 / 1.71%
  • Shares traded--
  • 1 Year change-13.71%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 17:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in domestic market.

  • Revenue in HKD (TTM)496.77m
  • Net income in HKD-154.85m
  • Incorporated2015
  • Employees164.00
  • Location
    CStone Pharmaceuticals1000 Zhangheng Road Bldg 25Pudong New DistrictSUZHOU 200072ChinaCHN
  • Phone+86 51 287186550
  • Websitehttps://www.cstonepharma.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.